KeithStuartMD
Oncology • Burlington, MAGastrointestinal Cancer, Hematologic Oncology
Chair, Hematology/Oncology, Lahey Hospital & Medical Center,
Dr. Stuart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
41 Mall Rd
Burlington, MA 01805Phone+1 781-744-8400Fax+1 781-744-5359- Is this information wrong?
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1991- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
Albert Einstein College of MedicineClass of 1985
Certifications & Licensure
MA State Medical License 1988 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top MD Consumers Checkbook
Clinical Trials
- Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver Start of enrollment: 1999 Dec 15
- Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) Start of enrollment: 2009 Feb 01
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsCapecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinomaAndrea J. Bullock, Keith Stuart, Susanna Jacobus, Thomas A. Abrams, Raymond C. Wadlow, Michael Goldstein, Rebecca A. Miksad> ;Journal of Gastrointestinal Oncology. 2017 Jul 26
- 121 citationsA phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocel...Andrew X. Zhu, Richard S. Finn, Mary F. Mulcahy, Jayne Gurtler, Weijing Sun, Jonathan D. Schwartz, Rita P. Dalal, Adarsh Joshi, Rebecca R. Hozak, Yihuan Xu, Marek Ancu...> ;Clinical Cancer Research. 2013 Dec 1
- 61 citationsA prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumorJennifer A. Chan, Lawrence S. Blaszkowsky, Keith Stuart, Andrew X. Zhu, Jill N. Allen, Raymond C. Wadlow, David P. Ryan, Jeffrey A. Meyerhardt, Marielle Gonzalez, Eile...> ;Cancer. 2013 Sep 1
- Join now to see all
Other
- Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolizationStuart KE, Schwartz JM, Carithers RL, Curley SA
http://www.uptodate.com/contents/nonsurgical-therapies-for-localized-hepatocellular-carcinoma-transa
UpToDate, Wolters Kluwer Health - 2013-02-21 - Systemic therapy for advanced cholangiocarcinomaStuart KE
http://www.uptodate.com/contents/systemic-therapy-for-advanced-cholangiocarcinoma
UpToDate, Wolters Kluwer Health - 2012-10-01 - Systemic treatment for advanced hepatocellular carcinomaStuart KE
http://www.uptodate.com/contents/systemic-treatment-for-advanced-hepatocellular-carcinoma
UpToDate, Wolters Kluwer Health - 2013-02-21 - Join now to see all
Press Mentions
First Thing: 'Petulant' Trump Wore Mask on Factory Visit – but Not in PublicMay 22nd, 2020
Lahey’s ‘Top Docs’ HonoredDecember 8th, 2017
He Expands Cancer Care in the SuburbsJanuary 15th, 2007- Join now to see all
Hospital Affiliations
Tufts Medical CenterBoston, Massachusetts
Lahey Hospital & Medical CenterBurlington, Massachusetts
Beverly HospitalBeverly, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
